Roche Holding AG (OTCMKTS:RHHBY) Receives $50.00 Consensus PT from Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been assigned an average rating of “Buy” from the five research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a buy recommendation and three have given a strong buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $50.00.

Several equities analysts have commented on the stock. Morgan Stanley reissued an “underweight” rating on shares of Roche in a research note on Wednesday. Hsbc Global Res raised shares of Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 2nd. HSBC upgraded shares of Roche from a “hold” rating to a “buy” rating and set a $50.00 target price on the stock in a report on Thursday, October 2nd. Finally, Jefferies Financial Group downgraded shares of Roche from a “hold” rating to a “moderate sell” rating in a report on Monday.

Roche Price Performance

Roche stock opened at $40.61 on Tuesday. The company’s 50-day moving average price is $42.47 and its two-hundred day moving average price is $40.77. Roche has a 52 week low of $34.10 and a 52 week high of $45.94.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. GAMMA Investing LLC boosted its holdings in shares of Roche by 59.5% during the first quarter. GAMMA Investing LLC now owns 12,850 shares of the company’s stock worth $529,000 after purchasing an additional 4,794 shares during the period. Moloney Securities Asset Management LLC grew its position in Roche by 53.8% during the first quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company’s stock valued at $1,672,000 after purchasing an additional 14,245 shares in the last quarter. S&CO Inc. grew its position in Roche by 4.1% during the first quarter. S&CO Inc. now owns 51,199 shares of the company’s stock valued at $2,101,000 after purchasing an additional 2,014 shares in the last quarter. North Star Asset Management Inc. lifted its stake in Roche by 7.8% in the first quarter. North Star Asset Management Inc. now owns 17,305 shares of the company’s stock valued at $712,000 after acquiring an additional 1,255 shares during the last quarter. Finally, PNC Financial Services Group Inc. lifted its stake in Roche by 2.0% in the first quarter. PNC Financial Services Group Inc. now owns 16,234 shares of the company’s stock valued at $668,000 after acquiring an additional 323 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.